Cyclin D1 protein and CCND1 gene expression in colorectal cancer.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 15993030)

Published in Eur J Surg Oncol on September 01, 2005

Authors

E Balcerczak1, G Pasz-Walczak, P Kumor, M Panczyk, R Kordek, R Wierzbicki, M Mirowski

Author Affiliations

1: Molecular Biology Laboratory, Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University, Muszynskiego 1 Street, 90-151 Lodz, Poland.

Articles by these authors

Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med (1980) 3.12

Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer (2006) 2.68

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am J Pathol (2000) 1.79

Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology (1995) 1.62

BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat (2006) 1.33

Standby automatic defibrillator. An approach to prevention of sudden coronary death. Arch Intern Med (1970) 1.21

The development of the transvenous automatic defibrillator. Arch Intern Med (1972) 1.19

Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study. J Clin Oncol (1990) 1.16

WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol (2005) 1.15

Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer. J Clin Oncol (1990) 1.13

The automatic implantable cardioverter-defibrillator: an overview. J Am Coll Cardiol (1985) 1.06

Left atrial rhythm; diagnostic criteria and differentiation from nodal arrhythmias. Am J Cardiol (1966) 1.05

Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. Cancer Genet Cytogenet (2001) 1.05

Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death. Am J Cardiol (1983) 1.04

Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol (1998) 1.03

Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer. Hepatogastroenterology (1997) 1.02

Mortality in patients with implanted automatic defibrillators. Ann Intern Med (1983) 1.01

Considerations in the development of the automatic implantable defibrillator. Med Instrum (1976) 1.00

Clinical experience with the automatic implantable defibrillator. Arch Mal Coeur Vaiss (1985) 0.99

Feasibility and effectiveness of low-energy catheter defibrillation in man. Circulation (1973) 0.97

The automatic implantable defibrillator. Am Heart J (1980) 0.94

Cyclin E expression in breast cancer correlates with negative steroid receptor status, HER2 expression, tumor grade and proliferation. J Exp Clin Cancer Res (2006) 0.93

The occurrence and mechanism of P-wave inversion in lead I in right atrial overloading. Report of two cases. Am Heart J (1966) 0.93

Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias. Neoplasma (2002) 0.92

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53. Br J Cancer (2008) 0.91

Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer. J Clin Oncol (1992) 0.91

P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis. Pathol Res Pract (2001) 0.91

Carcinosarcoma of the skin. Case report and literature review. Am J Dermatopathol (1996) 0.91

Astonishingly rapid growth of malignant cystosarcoma phyllodes tumor in a pregnant woman--a case report. Int J Gynecol Cancer (2007) 0.91

HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma. Langenbecks Arch Surg (2004) 0.90

Treatment of myocardial infarction in a community hospital coronary care unit. Experience with 1,246 patients. Arch Intern Med (1978) 0.90

Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillator. Am Heart J (1981) 0.90

Patterns of ventricular activity during catheter defibrillation. Circulation (1974) 0.88

Ectopic right atrial rhythms: experimental and clinical data. Am Heart J (1971) 0.88

Expression of the p65 gene in patients with colorectal cancer: comparison with some histological typing, grading and clinical staging. Eur J Surg Oncol (2004) 0.88

Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients. Clin Neuropathol (2003) 0.88

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome. Eur J Haematol (2002) 0.87

Implantation of the automatic defibrillator: the subxiphoid approach. Ann Thorac Surg (1982) 0.87

Blood coagulation changes in rats poisoned with methylmercuric chloride (MeHg). Pol J Pharmacol Pharm (1990) 0.87

Peculiar focal myocardial degeneration and fatal ventricular arrhythmias in a child. N Engl J Med (1972) 0.87

Clinical performance of the implantable cardioverter-defibrillator. Pacing Clin Electrophysiol (1984) 0.87

Evaluation of oestrogen receptor expression in breast cancer by quantification of mRNA. Histopathology (2007) 0.86

HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging. Pathol Res Pract (2003) 0.86

Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur. Leuk Lymphoma (2001) 0.86

Maltol (3-hydroxy-2-methyl-4-pyrone) toxicity in neuroblastoma cell lines and primary murine fetal hippocampal neuronal cultures. Neurodegeneration (1996) 0.84

Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am J Cardiol (1987) 0.83

Impending sudden cardiac death: treatment with myocardial revascularization and the automatic implantable cardioverter defibrillator. Ann Thorac Surg (1988) 0.83

Left atrial impulse formation in atrial flutter. Br Heart J (1967) 0.83

Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients. Neoplasma (2011) 0.83

Cutaneous multifocal melanoma metastases clinically resembling herpes zoster. J Eur Acad Dermatol Venereol (2006) 0.83

Propranolol in supraventricular tachycardias of childhood. Arch Dis Child (1973) 0.83

Ectopic rhythms originating anteriorly in the left atrium. Analysis of 12 cases with P-wave inversion in all precordial leads. Am Heart J (1967) 0.82

Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland. Folia Histochem Cytobiol (2003) 0.82

Quantitative analysis of the p65 gene expression in patients with coloroctal cancer. Int J Biomed Sci (2007) 0.82

Ultrastructural pathology of glial brain tumors revisited: a review. Ultrastruct Pathol (1997) 0.82

The automatic implantable defibrillator. New Modality for treatment of life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol (1982) 0.81

The spatial characteristics of atrial activation in ventriculo-atrial excitation. Chest (1970) 0.81

Content of mercury in chromatin and level of metallothionein proteins in kidneys and liver of rats. Biochem Pharmacol (1981) 0.81

Binding of mercury by chromatin of rats exposed to mercuric chloride. Environ Res (1979) 0.81

Studies on left atrial automaticity in dogs. Circ Res (1970) 0.81

Prevention of sudden arrhythmic death with implanted automatic defibrillators. Ann Intern Med (1982) 0.81

A chronically implanted system for automatic defibrillation in active conscious dogs. Experimental model for treatment of sudden death from ventricular fibrillation. Circulation (1978) 0.81

Studies on the methylation status of CpG sequences located in promoters of selected tumour suppressor genes in breast cancer cells. Nucleosides Nucleotides Nucleic Acids (2006) 0.80

Effect of mercuric chloride on cultured rat fibroblasts: survival, protein biosynthesis and binding of mercury to chromatin. Biochem Pharmacol (1983) 0.80

Apoptosis in relation to neuronal loss in experimental Creutzfeldt-Jakob disease in mice. Acta Neurobiol Exp (Wars) (2001) 0.80

A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas. Pol J Pathol (1998) 0.80

Coagulation and fibrinolysis in rats poisoned with mercuric chloride. Pol J Pharmacol Pharm (1989) 0.80

Monoclonal antibodies against a 65-kDa tumor-associated phosphoprotein: development and use in cancer detection. Hybridoma (1993) 0.80

Usefulness of polyclonal antibodies raised against P65 oncofetal protein in immunohistochemical diagnosis of ductal breast cancer. J Exp Clin Cancer Res (2004) 0.80

Chicken reticulocyte nuclear antigen: its identification and relation to transcriptive activity in erythropoietic cells. Biochemistry (1980) 0.80

Transvenous catheter defibrillation for prevention of sudden cardiac death. J Am Coll Cardiol (1988) 0.80

Pathologic findings related to the lead system and repeated defibrillations in patients with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol (1987) 0.80

Systematic administration of chloroquine in discoid lupus erythematosus reduces skin lesions via inhibition of angiogenesis. Clin Exp Dermatol (2008) 0.80

Expression of p65, DD3 and c-erbB2 genes in prostate cancer. Neoplasma (2003) 0.80

p65 and c-erbB2 genes expression in breast tumors: comparison with some histological typing, grading and clinical staging. J Exp Clin Cancer Res (2003) 0.79

Expression of p65 gene in experimental colon cancer under the influence of 5-fluorouracil given alone and in combination with hormonal modulation. Neoplasma (2004) 0.79

Desmoplastic cerebral astrocytoma of infancy: a case report. Folia Neuropathol (1998) 0.79

Papillary eccrine adenoma--a case of cutaneous sweat gland tumor with secretory and ductular differentiation. Pol J Pathol (1994) 0.78

Association of loss of heterozygosity with shorter survival in primary glioblastoma patients. Pol J Pathol (2013) 0.78

Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol (1991) 0.78

Intraosseous orbital haemangioma. Folia Neuropathol (2001) 0.78

VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer. Eur J Cancer (1994) 0.78

Surgical techniques for implanting the automatic implantable defibrillator. Pacing Clin Electrophysiol (1984) 0.78

A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group. J Immunother (1991) (1992) 0.78

Molecular analysis of PRNP gene in Polish population and in Creutzfeldt-Jakob disease. Folia Neuropathol (1999) 0.78

Use of alternating current during diagnostic electrophysiologic studies. Circulation (1983) 0.77

Dysembryoplastic neuroectodermal tumor: an ultrastructural study of six cases. Ultrastruct Pathol (2002) 0.77

Procoagulant activity of human stomach and colon cancers. Oncology (1990) 0.77

Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease. Folia Neuropathol (1997) 0.77

Biologic heterogeneity of angiomatous meningiomas. Pol J Pathol (1998) 0.77